EPREX STERILE SOLUTION 8000 IU/0.8 ML 8000 UNIT / 0.8 ML
EPOETIN ALFA : 8000 UNIT / 0.8 ML · DIN 02243403 · JANSSEN INC
Health Canada status: MARKETED
What is EPREX STERILE SOLUTION 8000 IU/0.8 ML?
EPREX STERILE SOLUTION 8000 IU/0.8 ML 8000 UNIT / 0.8 ML contains EPOETIN ALFA : 8000 UNIT / 0.8 ML. It is listed in the Health Canada Drug Product Database under DIN 02243403, held by JANSSEN INC, supplied as SOLUTION for SUBCUTANEOUS ; INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 20-Feb-2001. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is EPREX STERILE SOLUTION 8000 IU/0.8 ML used for?
EPREX® (epoetin alfa) is indicated to elevate or maintain the red blood cell level (as manifested by the hematocrit or hemoglobin determinations) and to decrease the need for transfusions. EPREX is indicated for the treatment of anemia associated with chronic renal failure (CRF), the treatment of transfusion-dependent anemia related to therapy with zidovudine in HIV-infected patients, the treatment of anemia due to the effect of concomitantly administered chemotherapy, and the treatment of patients who are undergoing major elective surgery to reduce allogeneic blood transfusions and hasten erythroid recovery.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is EPREX STERILE SOLUTION 8000 IU/0.8 ML called?
The same molecule, ERYTHROPOIETIN, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Recormon Pre-Filled | Latin | South Africa |
| Eprex Prefill | Latin | South Africa |
| Recormon | Latin | South Africa |
| Recormon Vials | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02243403 |
|---|---|
| Brand name | EPREX STERILE SOLUTION 8000 IU/0.8 ML |
| Generic / active ingredient | EPOETIN ALFA : 8000 UNIT / 0.8 ML |
| Manufacturer | JANSSEN INC |
| Strength | 8000 UNIT / 0.8 ML |
| Dosage form | SOLUTION |
| Route of administration | SUBCUTANEOUS ; INTRAVENOUS |
| Schedule | Prescription |
| ATC code | B03XA01 ERYTHROPOIETIN |
| AHFS class | 20:16.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 20-Feb-2001 |
| Original market date | 2001-02-20 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02243403 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2243403 |
| Brand name | EPREX STERILE SOLUTION 8000 IU/0.8 ML |
| Active ingredient / INN | EPOETIN ALFA : 8000 UNIT / 0.8 ML |
| ATC code | B03XA01 |
| ATC anatomical main group | B — Blood and blood-forming organs |
| ATC therapeutic subgroup | B03 |
| AHFS class | 20:16.00 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | JANSSEN INC |
How is it stored and handled?
null
How is it supplied?
Single-use pre-filled syringes with PROTECS® needle guard: 1000 IU/0.5 mL, 2000 IU/0.5 mL, 3000 IU/0.3 mL, 4000 IU/0.4 mL, 5000 IU/0.5 mL, 6000 IU/0.6 mL, 8000 IU/0.8 mL, 10 000 IU/mL, 20 000 IU/0.5 mL, 30 000 IU/0.75 mL, 40 000 IU/mL
Which pack is which?
| Strength on the label | 8000 UNIT / 0.8 ML |
|---|---|
| Dosage form | SOLUTION |
| Route | SUBCUTANEOUS ; INTRAVENOUS |
| Packaging as described in the monograph | Single-use pre-filled syringes with PROTECS® needle guard: 1000 IU/0.5 mL, 2000 IU/0.5 mL, 3000 IU/0.3 mL, 4000 IU/0.4 mL, 5000 IU/0.5 mL, 6000 IU/0.6 mL, 8000 IU/0.8 mL, 10 000 IU/mL, 20 000 IU/0.5 mL, 30 000 IU/0.75 mL, 40 000 IU/mL |
| Storage | null |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
What can be used instead?
Other Canadian products sharing ATC code B03XA01 ERYTHROPOIETIN. 11 of 15 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| EPREX STERILE SOLUTION | 20000 UNIT / 0.5 ML | SOLUTION | JANSSEN INC | MARKETED | DIN 02243239 |
| EPREX STERILE SOLUTION | 30000 UNIT / 0.75 ML | SOLUTION | JANSSEN INC | MARKETED | DIN 02288680 |
| EPREX STERILE SOLUTION 10000IU/1.0ML | 10000 UNIT | SOLUTION | JANSSEN INC | MARKETED | DIN 02231587 |
| EPREX STERILE SOLUTION 1000IU/0.5ML | 1000 UNIT / 0.5 ML | SOLUTION | JANSSEN INC | MARKETED | DIN 02231583 |
| EPREX STERILE SOLUTION 2000IU/0.5ML | 2000 UNIT / 0.5 ML | SOLUTION | JANSSEN INC | MARKETED | DIN 02231584 |
| EPREX STERILE SOLUTION 3000IU/0.3ML | 3000 UNIT / 0.3 ML | SOLUTION | JANSSEN INC | MARKETED | DIN 02231585 |
| EPREX STERILE SOLUTION 40000IU/ML | 40000 UNIT | SOLUTION | JANSSEN INC | MARKETED | DIN 02240722 |
| EPREX STERILE SOLUTION 4000IU/0.4ML | 4000 UNIT / 0.4 ML | SOLUTION | JANSSEN INC | MARKETED | DIN 02231586 |
| EPREX STERILE SOLUTION 5000IU/0.5ML | 5000 UNIT / 0.5 ML | SOLUTION | JANSSEN INC | MARKETED | DIN 02243400 |
| EPREX STERILE SOLUTION 6000 IU/0.6 ML | 6000 UNIT / 0.6 ML | SOLUTION | JANSSEN INC | MARKETED | DIN 02243401 |
Who else supplies ERYTHROPOIETIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ERYTHROPOIETIN appears in 41 registered pack listings across 3 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does ERYTHROPOIETIN cost around the world?
ERYTHROPOIETIN is listed on 2 national price registers Nexara tracks, across 40 pack listings published on 2 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| Greece | producer price (ex-factory) | 22 | 22 | 03 Sep 2026 |
| South Africa | single exit price | 12 | 18 | 01 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.